These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9823572)

  • 61. [Chronic hepatitis C: current treatment and perspectives].
    Negro F
    Rev Med Suisse; 2011 Jan; 7(279):212-3. PubMed ID: 21387717
    [No Abstract]   [Full Text] [Related]  

  • 62. Hepatitis C anno 1997.
    Schalm SW
    Neth J Med; 1997 Dec; 51(6):195-7. PubMed ID: 9499689
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of interferon therapy on viral titers in patients with chronic hepatitis C who are positive for hepatitis GB virus C.
    Chayama K; Kobayashi M; Ikeda K; Kumada H
    J Hepatol; 1997 Oct; 27(4):769-70. PubMed ID: 9365058
    [No Abstract]   [Full Text] [Related]  

  • 64. [Uncommon adverse effects after interferon therapy in patients with hepatitis C].
    Pisabarros Blanco C; Álvarez Cuenllas B; Gutiérrez Torices C; Linares Torres P; Vivas Alegre S
    Gastroenterol Hepatol; 2013 Dec; 36(10):624-5. PubMed ID: 24018313
    [No Abstract]   [Full Text] [Related]  

  • 65. Chronic hepatitis C.
    Agarwal K; Cross TJ; Gore C
    BMJ; 2007 Jan; 334(7584):54-5. PubMed ID: 17218670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis C virus infection: from margin to center in rhode island and beyond.
    Taylor LE
    R I Med J (2013); 2014 Jul; 97(7):15-6. PubMed ID: 24983015
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Discussions on treatment failure causes and principles of chronic hepatitis C patients].
    Xie Q; Guo SM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):417-9. PubMed ID: 24490305
    [No Abstract]   [Full Text] [Related]  

  • 68. Antiviral chemotherapy and interferon.
    Br Med Bull; 1985 Oct; 41(4):307-405. PubMed ID: 2413947
    [No Abstract]   [Full Text] [Related]  

  • 69. [Management of psychological disorders in patients with chronic hepatitis C].
    De Montjoye BB; Ferrand I; Sogni P; Podevin P
    Encephale; 2006; 32(2 Pt 1):198-203. PubMed ID: 16910620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Anti-viral therapy of type C chronic hepatitis. 1. The current status of interferon therapy: evidence for the standard therapy].
    Sakamoto M; Enomoto N
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):57-63. PubMed ID: 18360971
    [No Abstract]   [Full Text] [Related]  

  • 71. African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans.
    Borum ML; Igiehon E; Shafa S
    Dig Dis Sci; 2009 Jul; 54(7):1604; author reply 1604-5. PubMed ID: 19399619
    [No Abstract]   [Full Text] [Related]  

  • 72. [New therapies in chronic hepatitis].
    Dehesa-Violante M
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():87-9. PubMed ID: 22939494
    [No Abstract]   [Full Text] [Related]  

  • 73. [Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 2) Participation of host factors].
    Ikejima K; Yaginuma R; Watanabe S
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):69-74. PubMed ID: 18360973
    [No Abstract]   [Full Text] [Related]  

  • 74. Interferon: an early evaluation.
    McCredie KB; Moore MS
    J Indiana State Med Assoc; 1980 Sep; 73(9):576-8. PubMed ID: 6158538
    [No Abstract]   [Full Text] [Related]  

  • 75. [Isolated chronic cough during interferon therapy].
    Pileire G; Leclerc P; Hermant P; Meeus E; Camus P
    Presse Med; 1999 May 1-8; 28(17):913. PubMed ID: 10360188
    [No Abstract]   [Full Text] [Related]  

  • 76. [Interferon].
    Béládi I
    Orv Hetil; 1982 Jun; 123(24):1471-7. PubMed ID: 6180376
    [No Abstract]   [Full Text] [Related]  

  • 77. The efficacy, limitations, and outcomes of our current interferon-based therapies for hepatitis C.
    Kwo PY; Sozio MS
    Gastroenterology; 2013 Dec; 145(6):1488-90. PubMed ID: 24409497
    [No Abstract]   [Full Text] [Related]  

  • 78. [Chronic hepatitis C: controversies, challenges and future goals].
    Wei L
    Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):993-4. PubMed ID: 22333163
    [No Abstract]   [Full Text] [Related]  

  • 79. [Molecular physiopathology of viral hepatitis].
    Hayashi N; Kanto T; Hosui A; Sugimoto Y; Okawa K; Takehara T; Sasaki Y
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():89-93. PubMed ID: 12577933
    [No Abstract]   [Full Text] [Related]  

  • 80. [Future perspectives of treatment of chronic hepatitis C].
    Chayama K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(1):25-8. PubMed ID: 26743550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.